Clinical Trial Update: TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy [Phase 2]

View source ↗

Summary

Phase 2 trial TXV13-01 assessed estradiol vaginal softgel capsules for postmenopausal vulvar and vaginal atrophy. The study has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspareunia
• Menopause
• Vulvar and Vaginal Atrophy

Drugs mentioned

• TXV13-01 Estradiol Vaginal Softgel Capsule (estradiol)

Snippet

Sponsor: TherapeuticsMD | Conditions: Menopause, Vulvovaginal Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2015-12-14